Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D and Grass Pollen Specific Immunotherapy
NCT01466465Phase 2Completed
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Oct 2011
- Primary completion
- Jan 2015
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of vitamin d in allergic rhinoconjunctivitis (ARC), sponsored by Charité – Universitätsmedizin Berlin. Started Oct 2011; status: completed.
02
Drugs
vitamin d
03
Conditions
allergic rhinoconjunctivitis (ARC)
Beyond the preview
Go deeper on NCT01466465.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01466465.